Cardinal Health expands Ac-225 production
This increases domestic supply of the cancer-targeting radionuclide, advancing radiopharmaceuticals for patients.
See the latest news and media coverage for Cardinal Health. We track all announcements, press releases, and industry mentions in real time, all in one place.
Healthcare services and supplies distributor
cardinalhealth.comLast updated
In short: Cardinal Health raised its 2026 financial outlook following strong earnings driven by specialty drug demand and strategic operational investments.
This increases domestic supply of the cancer-targeting radionuclide, advancing radiopharmaceuticals for patients.
Revenue rises 11% to $60.9B. Non-GAAP EPS increases 35% to $3.17. Raises FY2026 outlook to $10.70-$10.80.
Velocare scales hospital-at-home programs nationwide.
The expansion at its Indianapolis center increases cGMP-compliant supply for novel cancer therapies amid growing demand. It supports over 15 clinical trials worldwide.
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and...
Faber’s verdict was appealed to the Fourth Circuit Court of Appeals which remanded the case back to ...
Growth Stocks - Spot market reversals with our contrarian sentiment indicators. Cardinal Health Inc. (CAH) reported fiscal first-quarter 2026 earnings per share of $3.17, significantly...
Earlier this month, Cardinal Health, Inc. declared a quarterly dividend of US$0.5158 per share,...
Track Cardinal Health and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to Cardinal Health and other trending companies.